Laura Hogenboom

5PUBLICATIONS
14CO-AUTHORS
Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Information modelling, management and ontologiesHaematological tumoursCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 29, 2026
Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis.

|Jul 07, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

|May 19, 2026
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactions.

|May 08, 2026
Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts.

|Oct 18, 2024
Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.

Zoë Ygj van Lierop, Mark Hj Wessels, Womei Ml Lekranty

Pageof 1

Frequent Collaborators

4 joint publications

Eva Mm Strijbis

3 joint publications

Zoé LE van Kempen

3 joint publications

Lisa Schoof

2 joint publications

Joep Killestein